TY  - GEN
AU  - Havlir,Diane V
AU  - Kendall,Michelle A
AU  - Ive,Prudence
AU  - Kumwenda,Johnstone
AU  - Swindells,Susan
AU  - Qasba,Sarojini S
AU  - Luetkemeyer,Anne F
AU  - Hogg,Evelyn
AU  - Rooney,James F
AU  - Wu,Xingye
AU  - Hosseinipour,Mina C
AU  - Lalloo,Umesh
AU  - Veloso,Valdilea G
AU  - Some,Fatuma F
AU  - Kumarasamy,N
AU  - Padayatchi,Nesri
AU  - Santos,Breno R
AU  - Reid,Stewart
AU  - Hakim,James
AU  - Mohapi,Lerato
AU  - Mugyenyi,Peter
AU  - Sanchez,Jorge
AU  - Lama,Javier R
AU  - Pape,Jean W
AU  - Sanchez,Alejandro
AU  - Asmelash,Aida
AU  - Moko,Evans
AU  - Sawe,Fred
AU  - Andersen,Janet
AU  - Sanne,Ian
TI  - Timing of antiretroviral therapy for HIV-1 infection and tuberculosis
SN  - 1533-4406
PY  - 2011///1102
KW  - AIDS-Related Opportunistic Infections
KW  - drug therapy
KW  - Adult
KW  - Anti-Retroviral Agents
KW  - administration & dosage
KW  - Antitubercular Agents
KW  - therapeutic use
KW  - CD4 Lymphocyte Count
KW  - Drug Administration Schedule
KW  - Female
KW  - HIV Infections
KW  - complications
KW  - HIV-1
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Tuberculosis
N1  - Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1056/NEJMoa1013607
ER  -